|
|
|
|
<navbar custom-style="background:{{background}}" fixed>
|
|
|
|
|
<van-icon name="arrow-left" slot="left" size="18px" color="#000" bind:tap="handleBack" />
|
|
|
|
|
</navbar>
|
|
|
|
|
<view
|
|
|
|
|
class="page"
|
|
|
|
|
style="background: url('{{imageUrl}}bg15.png?t={{Timestamp}}') no-repeat top center/100% 518rpx;padding-top:{{pageTop+20}}px;"
|
|
|
|
|
>
|
|
|
|
|
<view class="module1" style="background: url('{{imageUrl}}bg16.png?t={{Timestamp}}') no-repeat top center/100%">
|
|
|
|
|
<view class="content">
|
|
|
|
|
<view>
|
|
|
|
|
研究表明，GO-QOL生活质量评估能敏锐反映患者的主观感受变化，是评估治疗效果的重要工具。
|
|
|
|
|
<text class="reference">[1]</text>
|
|
|
|
|
</view>
|
|
|
|
|
<view>它不仅能帮你看清自己“主观世界”的变化还能成为你和医生沟通的重要桥梁。</view>
|
|
|
|
|
</view>
|
|
|
|
|
<view class="container">
|
|
|
|
|
<view class="title">适用场景</view>
|
|
|
|
|
<view class="progress">
|
|
|
|
|
<view class="row">
|
|
|
|
|
<view class="aside">
|
|
|
|
|
<view class="line-top" style="opacity: 0"></view>
|
|
|
|
|
<view class="side"></view>
|
|
|
|
|
<view class="line"></view>
|
|
|
|
|
</view>
|
|
|
|
|
<view class="r-content">
|
|
|
|
|
<text class="name">初诊时:</text>
|
|
|
|
|
作为基线记录生活影响
|
|
|
|
|
<text class="reference">[3]</text>
|
|
|
|
|
</view>
|
|
|
|
|
</view>
|
|
|
|
|
<view class="row">
|
|
|
|
|
<view class="aside">
|
|
|
|
|
<view class="line-top"></view>
|
|
|
|
|
<view class="side"></view>
|
|
|
|
|
<view class="line"></view>
|
|
|
|
|
</view>
|
|
|
|
|
<view class="r-content">
|
|
|
|
|
<text class="name">诊疗中:</text>
|
|
|
|
|
分数上升说明主观改善
|
|
|
|
|
<text class="reference">[4]</text>
|
|
|
|
|
</view>
|
|
|
|
|
</view>
|
|
|
|
|
<view class="row">
|
|
|
|
|
<view class="aside">
|
|
|
|
|
<view class="line-top"></view>
|
|
|
|
|
<view class="side"></view>
|
|
|
|
|
<view class="line"></view>
|
|
|
|
|
</view>
|
|
|
|
|
<view class="r-content">
|
|
|
|
|
<text class="name">病情期:</text>
|
|
|
|
|
判断是否还需更多支持
|
|
|
|
|
<text class="reference">[2-3]</text>
|
|
|
|
|
</view>
|
|
|
|
|
</view>
|
|
|
|
|
</view>
|
|
|
|
|
</view>
|
|
|
|
|
<view class="tip">
|
|
|
|
|
共
|
|
|
|
|
<text class="num">16</text>
|
|
|
|
|
题，可能会占用您3分钟
|
|
|
|
|
</view>
|
|
|
|
|
</view>
|
|
|
|
|
<view class="module2">
|
|
|
|
|
<view class="title">参考文献:</view>
|
|
|
|
|
<view class="content">
|
|
|
|
|
<view>
|
|
|
|
|
[1]Kahaly, George J et al.“Teprotumumab lmproves Quality of Life in Thyroid Eye Disease: Meta-analysis and
|
|
|
|
|
Matching adjusted Indirect Comparison." Journal of the EndocrineSociety vol.9,6 bvaf063.8 Apr.2025
|
|
|
|
|
</view>
|
|
|
|
|
<view>
|
|
|
|
|
[2] Lee, T.H.B., & Sundar, G.(2020). Quality of Life in ThyroidEye Disease: A Systematic Review.Ophthalmic
|
|
|
|
|
plastic andreconstructive surgery,36(2),118-126.
|
|
|
|
|
</view>
|
|
|
|
|
<view>
|
|
|
|
|
[3] Dietrich A, Taylor P, White P, et al. Establishing theusefulness of the GO-QOL in a UK hospital-treated
|
|
|
|
|
populationwith thyroid eye disease in the ClRTED trial. Psychol HealthMed.2018;23(sup1):1341-1355.
|
|
|
|
|
</view>
|
|
|
|
|
<view>
|
|
|
|
|
[4] Smith TJ, Cockerham K, Barretto N, et al. Bridging andValidation of the Specific Graves Ophthalmopathy
|
|
|
|
|
Quality ofLife Questionnaire With Health State Utility Values. EndocrPract.2024;30(5):470-475.
|
|
|
|
|
</view>
|
|
|
|
|
</view>
|
|
|
|
|
</view>
|
|
|
|
|
<view class="footer">
|
|
|
|
|
<button class="share" open-type="share">
|
|
|
|
|
<image class="icon" src="{{imageUrl}}icon69.png?t={{Timestamp}}"></image>
|
|
|
|
|
<view class="name">分享</view>
|
|
|
|
|
</button>
|
|
|
|
|
<view class="btn" bind:tap="handleAdd">开始评测</view>
|
|
|
|
|
</view>
|
|
|
|
|
</view>
|
